PSI Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

PSI Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,400	Closed	-$5K	–	651
2019 Q4	$5K	Buy	+1,400	New	+$11.3K	﹤0.01%	559

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PSI Advisors's SPPI Position: Q1 2020 in Review

PSI Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 1,400 shares — an estimated $5K sold.

PSI Advisors first reported a position in SPPI in Q4 2019 and held it in 1 quarter. The position peaked at $5K in Q4 2019. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

PSI Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
PSI Advisors sold 1,400 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $5K.
PSI Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2019 and held it in 1 quarter.
PSI Advisors's Spectrum Pharmaceuticals Inc position peaked at $5K in Q4 2019.
156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on PSI Advisors's 13F filing for Q1 2020, filed 15 May 2020.